End-to-end manufacturing solutions provider ACG, announces the opening of its capsule production plant in Pouso Alegre-Minas Gerais, Brazil, in addition to expansions to its factories in Croatia and India.
ACG made an investment of R$350m Brazilian ($98m) into the Brazilian facility, which spans 14,000m2. It will become the company’s second facility in the country after the group acquired Nova Nordeplast in 2017.
Both the new facility and the Nova Nordeplast plant in Sao Paulo will serve the entire Latin American region.
Senior VP of ACG Capsules, Kamlesh Oza will speak on behalf of the expanding facilities in India and Croatia which both specialize in hard capsules made with non-animal sourced gelatin and hydroxypropyl methylcellulose (HPMC), during DCAT week in New York.
“We are now keen to accelerate our growth, and to build long-term relations to serve our customers better,” a spokesperson for AGC said, regarding the company’s mission for growth.
“Establishing and expanding facilities around the world better positions ACG to accommodate a growing roster of clients within the industry,” added the spokesperson.
ACG’s Brazilian facility has met the standards set by the Brazilian Health Regulatory Agency (ANVISA), as well as passing good manufacturing practice (GMP) inspection by regulatory bodies.